Natural Sulfated Polysaccharides for the Prevention and Control of Viral Infections

Author(s):  
Carlos A. Pujol ◽  
María J. Carlucci ◽  
María C. Matulewicz ◽  
Elsa B. Damonte
1980 ◽  
Vol 1 (3) ◽  
pp. 165-182 ◽  
Author(s):  
William M. Valenti ◽  
Robert F. Betts ◽  
Caroline Breese Hall ◽  
Jerome F. Hruska ◽  
R. Gordon Douglas

AbstractThis article reviews the most likely mechanisms of transmission of the commonly encountered respiratory viruses (influenza, respiratory syncytial virus, parainfluenza, rhinovirus), herpesviruses, and hepatitis viruses, and presents the guidelines used currently for prevention and control that are in use at Strong Memorial Hospital.


2015 ◽  
Vol 3 (24) ◽  
pp. 4767-4779 ◽  
Author(s):  
Viktoriya Sokolova ◽  
Astrid Maria Westendorf ◽  
Jan Buer ◽  
Klaus Überla ◽  
Matthias Epple

Vaccination has a great impact on the prevention and control of infectious diseases. Nanoparticles can deliver immunoactive biomolecules to induce a virus-specific immune response.


2020 ◽  
Vol 5 (3) ◽  
pp. 123 ◽  
Author(s):  
Kefyalew Addis Alene ◽  
Kinley Wangdi ◽  
Archie C A Clements

Throughout history, pandemics of viral infections such as HIV, Ebola and Influenza have disrupted health care systems, including the prevention and control of endemic diseases. Such disruption has resulted in an increased burden of endemic diseases in post-pandemic periods. The current coronavirus disease 2019 (COVID-19) pandemic could cause severe dysfunction in the prevention and control of tuberculosis (TB), the infectious disease that causes more deaths than any other, particularly in low- and middle-income countries where the burden of TB is high. The economic and health crisis created by the COVID-19 pandemic as well as the public health measures currently taken to stop the spread of the virus may have an impact on household TB transmission, treatment and diagnostic services, and TB prevention and control programs. Here, we provide an overview of the potential impact of COVID-19 on TB programs and disease burden, as well as possible strategies that could help to mitigate the impact.


2021 ◽  
Author(s):  
Frank Adusei-Mensah ◽  
Richard O. Agjei ◽  
Luqman O. Awoniyi ◽  
David K. Lekpa ◽  
Fatima B. Awoniyi ◽  
...  

Introduction: Acute respiratory infections are continuously emerging. Discovered in Wuhan city, China in 2019, COV-SARS-2 and most viral respiratory diseases presently do not have a definitive cure. This paper aims to evaluate the therapeutic effectiveness of ginseng for the prevention and control of acute respiratory illness including SARS-COV-2 in the adult population. Method: We performed a systematic literature review using databases PubMed, Medline, Scopus, Google Scholar, Web of Science, and Cochrane library from 1st through the 27th of April 2020. All related articles that reported the use of Ginseng in COVID-19 patients were included in this analysis. The screening was done by 2-independent researchers. The meta-analysis was performed using a comprehensive meta-analysis package. Result: 596 articles were retrieved for the time frame. After screening, 5 articles with RCTs outcomes relevant to the review were selected. Ginseng was found to be effective in the reduction of risk by 38 % and 3-days shorter duration of acute respiratory illness (ARI) in all trials than placebo. Conclusion: As the world continues to race to find a cure, it is important to consider the use of ginseng which has been proven over the years to be effective in the treatment of acute respiratory illnesses. Further studies should however be conducted to determine the right dosage to improve efficacy and prevent adverse events.


1981 ◽  
Vol 2 (1) ◽  
pp. 38-49 ◽  
Author(s):  
William M. Valenti ◽  
Jerome F. Hruska ◽  
Marilyn A. Menegus ◽  
Mary Jane Freeburn

AbstractThis communication is the third in a four-part series on nosocomial viral infections from the Strong Memorial Hospital. This third article discusses guidelines for prevention and control of exanthematous viruses, gastroenteritis viruses, adenoviruses and the picornaviruses other than rhinoviruses. Several uncommonly seen viruses, such as the virus of Creutzfeldt-Jakob disease and Marburg, Ebola, and Lassa fever viruses, also are reviewed briefly.


2005 ◽  
Vol 24 (4, Suppl) ◽  
pp. S106-S110 ◽  
Author(s):  
Kevin D. McCaul ◽  
Ellen Peters ◽  
Wendy Nelson ◽  
Michael Stefanek

Sign in / Sign up

Export Citation Format

Share Document